Literature DB >> 22790440

The validity of routine brain MRI in detecting post-laminar optic nerve involvement in retinoblastoma.

Byung Joo Lee1, Jeong Hun Kim, Dong Hun Kim, Sung-Hye Park, Young Suk Yu.   

Abstract

OBJECTIVE: To describe the diagnostic validity of a gadolinium-enhanced routine brain MRI scan with 5 mm section thickness for the detection of optic nerve involvement in patients with retinoblastoma.
METHODS: Medical records of primarily enucleated retinoblastoma patients who underwent routine preoperative brain MRI scan with section thickness of 5 mm were retrospectively reviewed. Preoperative magnetic resonance images were independently reviewed in a masked fashion by two radiologists and compared with histological findings.
RESULTS: 41 eyes of 41 patients were included and the mean age at enucleation was 23.1 months. Among 41 eyes, 14 eyes were diagnosed to have post-laminar optic nerve invasion on histopathology. The accuracy, sensitivity and specificity of MRI for the diagnosis of post-laminar invasion were 73.2%, 35.7% and 92.6%, respectively, by the first radiologist and 78.0%, 42.9% and 96.3%, respectively, by the second radiologist. Moderate agreement was found between two radiologists (κ =0.48, p<0.01).
CONCLUSIONS: Compared with the results of previous studies using orbital MRI with less than 3 mm section thickness, routine brain MRI with section thickness of 5 mm showed comparable specificity but inferior sensitivity in detecting optic nerve involvement of retinoblastoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22790440     DOI: 10.1136/bjophthalmol-2012-301502

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

1.  High-resolution MRI using orbit surface coils for the evaluation of metastatic risk factors in 143 children with retinoblastoma: Part 1: MRI vs. histopathology.

Authors:  Selma Sirin; Marc Schlamann; Klaus A Metz; Norbert Bornfeld; Bernd Schweiger; Markus Holdt; Petra Temming; Michael M Schuendeln; Sophia L Goericke
Journal:  Neuroradiology       Date:  2015-06-04       Impact factor: 2.804

2.  Correlation between conventional MR imaging combined with diffusion-weighted imaging and histopathologic findings in eyes primarily enucleated for advanced retinoblastoma: a retrospective study.

Authors:  Yanfen Cui; Ran Luo; Ruifen Wang; Huanhuan Liu; Caiyuan Zhang; Zhongyang Zhang; Dengbin Wang
Journal:  Eur Radiol       Date:  2017-08-07       Impact factor: 5.315

3.  Assessment of early-stage optic nerve invasion in retinoblastoma using high-resolution 1.5 Tesla MRI with surface coils: a multicentre, prospective accuracy study with histopathological correlation.

Authors:  Hervé J Brisse; Pim de Graaf; Paolo Galluzzi; Kristel Cosker; Philippe Maeder; Sophia Göricke; Firazia Rodjan; Marcus C de Jong; Alexia Savignoni; Isabelle Aerts; Laurence Desjardins; Annette C Moll; Theodora Hadjistilianou; Paolo Toti; Paul van der Valk; Jonas A Castelijns; Xavier Sastre-Garau
Journal:  Eur Radiol       Date:  2014-11-30       Impact factor: 5.315

4.  High-resolution MRI using orbit surface coils for the evaluation of metastatic risk factors in 143 children with retinoblastoma: Part 2: new vs. old imaging concept.

Authors:  Selma Sirin; Marc Schlamann; Klaus A Metz; Norbert Bornfeld; Bernd Schweiger; Markus Holdt; Petra Temming; Michael M Schuendeln; Sophia L Goericke
Journal:  Neuroradiology       Date:  2015-05-08       Impact factor: 2.804

5.  Diagnostic performance of MRI of post-laminar optic nerve invasion detection in retinoblastoma: A systematic review and meta-analysis.

Authors:  Se Jin Cho; Jae Hyoung Kim; Sung Hyun Baik; Leonard Sunwoo; Yun Jung Bae; Byung Se Choi
Journal:  Neuroradiology       Date:  2020-08-31       Impact factor: 2.804

6.  Accuracy of preoperative imaging in predicting optic nerve invasion in retinoblastoma: A retrospective study.

Authors:  Usha Kim; Gunjan Rathi; Gunja Chowdhary; K G Srinavasan; R Shanthi; R S Prabhu Krishna
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.